Oscar Health, Inc.
OSCR
$13.23
$0.231.77%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.47% | 37.45% | 48.46% | 54.48% | 56.76% |
| Total Other Revenue | 38.96% | 13.74% | -7.19% | -12.34% | -3.64% |
| Total Revenue | 27.50% | 37.38% | 48.29% | 54.26% | 56.54% |
| Cost of Revenue | 36.64% | 46.21% | 57.70% | 57.44% | 57.96% |
| Gross Profit | -8.81% | 4.61% | 15.18% | 42.91% | 51.12% |
| SG&A Expenses | 16.76% | 21.21% | 27.91% | 29.74% | 23.13% |
| Depreciation & Amortization | -10.12% | -1.33% | -5.91% | -7.45% | 4.73% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.65% | 40.97% | 51.12% | 51.10% | 49.55% |
| Operating Income | -792.15% | -453.40% | -360.76% | 783.74% | 124.30% |
| Income Before Tax | -1,408.25% | -753.41% | -730.66% | 379.53% | 112.51% |
| Income Tax Expenses | -23.26% | -21.06% | 62.52% | 737.99% | 121.77% |
| Earnings from Continuing Operations | -1,795.58% | -924.38% | -980.17% | 332.12% | 109.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 64.01% | 46.20% | -442.45% | -678.85% | -414.18% |
| Net Income | -1,842.49% | -943.16% | -988.48% | 330.15% | 109.39% |
| EBIT | -792.15% | -453.40% | -360.76% | 783.74% | 124.30% |
| EBITDA | -510.99% | -299.72% | -220.78% | 2,152.58% | 143.63% |
| EPS Basic | -1,091.30% | -912.09% | -1,433.47% | 288.92% | 113.14% |
| Normalized Basic EPS | -925.55% | -743.38% | -938.36% | 326.68% | 115.74% |
| EPS Diluted | -2,057.25% | -1,959.52% | -600.63% | 153.07% | 93.26% |
| Normalized Diluted EPS | -5,674.21% | -1,418.92% | -454.22% | 173.70% | 97.45% |
| Average Basic Shares Outstanding | 9.14% | 7.87% | 8.46% | 8.91% | 8.45% |
| Average Diluted Shares Outstanding | 1.37% | 0.09% | 0.46% | 14.31% | 22.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |